Geneos Wealth Management Inc. Purchases 1,092 Shares of Oracle Co. (NYSE:ORCL)

Geneos Wealth Management Inc. boosted its position in Oracle Co. (NYSE:ORCL) by 6.2% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 18,828 shares of the enterprise software provider’s stock after acquiring an additional 1,092 shares during the quarter. Geneos Wealth Management Inc.’s holdings in Oracle were worth $2,365,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Invst LLC lifted its position in shares of Oracle by 2.7% in the 4th quarter. Invst LLC now owns 3,299 shares of the enterprise software provider’s stock worth $380,000 after purchasing an additional 86 shares during the period. Nemes Rush Group LLC lifted its position in shares of Oracle by 1.2% in the 4th quarter. Nemes Rush Group LLC now owns 7,334 shares of the enterprise software provider’s stock worth $773,000 after purchasing an additional 86 shares during the period. Avidian Wealth Solutions LLC raised its stake in shares of Oracle by 1.1% during the 4th quarter. Avidian Wealth Solutions LLC now owns 8,516 shares of the enterprise software provider’s stock worth $898,000 after acquiring an additional 90 shares in the last quarter. Sovereign Financial Group Inc. raised its stake in shares of Oracle by 2.9% during the 4th quarter. Sovereign Financial Group Inc. now owns 3,244 shares of the enterprise software provider’s stock worth $342,000 after acquiring an additional 90 shares in the last quarter. Finally, Godshalk Welsh Capital Management Inc. raised its stake in shares of Oracle by 0.3% during the 4th quarter. Godshalk Welsh Capital Management Inc. now owns 33,435 shares of the enterprise software provider’s stock worth $3,525,000 after acquiring an additional 90 shares in the last quarter. Institutional investors own 42.44% of the company’s stock.

Oracle Trading Up 0.5 %

Shares of ORCL traded up $0.69 during trading on Thursday, reaching $142.76. 5,235,406 shares of the company traded hands, compared to its average volume of 8,618,752. Oracle Co. has a twelve month low of $99.26 and a twelve month high of $145.79. The stock has a market cap of $393.43 billion, a PE ratio of 38.52, a price-to-earnings-growth ratio of 2.63 and a beta of 1.02. The stock has a 50-day simple moving average of $129.75 and a 200-day simple moving average of $120.27. The company has a quick ratio of 0.72, a current ratio of 0.71 and a debt-to-equity ratio of 8.25.

Oracle (NYSE:ORCL) last announced its quarterly earnings results on Tuesday, June 11th. The enterprise software provider reported $1.63 earnings per share for the quarter, missing analysts’ consensus estimates of $1.65 by ($0.02). Oracle had a net margin of 19.76% and a return on equity of 223.01%. The company had revenue of $14.29 billion for the quarter, compared to analyst estimates of $14.57 billion. During the same quarter in the prior year, the business earned $1.35 earnings per share. Oracle’s revenue was up 3.3% on a year-over-year basis. On average, analysts anticipate that Oracle Co. will post 5.01 earnings per share for the current year.

Oracle Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, July 25th. Stockholders of record on Thursday, July 11th will be paid a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 1.12%. The ex-dividend date is Thursday, July 11th. Oracle’s payout ratio is 43.13%.

Insider Activity

In other news, insider Edward Screven sold 235,918 shares of the firm’s stock in a transaction that occurred on Thursday, June 20th. The shares were sold at an average price of $144.30, for a total value of $34,042,967.40. Following the completion of the transaction, the insider now owns 2,626,764 shares of the company’s stock, valued at $379,042,045.20. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In related news, Director George H. Conrades sold 25,000 shares of Oracle stock in a transaction that occurred on Wednesday, May 1st. The shares were sold at an average price of $116.13, for a total value of $2,903,250.00. Following the completion of the transaction, the director now owns 17,836 shares in the company, valued at $2,071,294.68. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Edward Screven sold 235,918 shares of the business’s stock in a transaction that occurred on Thursday, June 20th. The stock was sold at an average price of $144.30, for a total transaction of $34,042,967.40. Following the transaction, the insider now owns 2,626,764 shares of the company’s stock, valued at approximately $379,042,045.20. The disclosure for this sale can be found here. Over the last quarter, insiders sold 385,639 shares of company stock valued at $53,002,729. 42.80% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several research firms recently commented on ORCL. TD Cowen boosted their price objective on shares of Oracle from $145.00 to $165.00 and gave the stock a “buy” rating in a research note on Wednesday, June 12th. UBS Group boosted their price objective on shares of Oracle from $150.00 to $160.00 and gave the stock a “buy” rating in a research note on Wednesday, June 12th. DA Davidson reiterated a “neutral” rating and set a $105.00 price objective on shares of Oracle in a research note on Wednesday, June 12th. Deutsche Bank Aktiengesellschaft upped their price target on shares of Oracle from $150.00 to $165.00 and gave the company a “buy” rating in a research note on Monday, June 17th. Finally, Bank of America upped their price target on shares of Oracle from $144.00 to $155.00 and gave the company a “neutral” rating in a research note on Wednesday, June 12th. Fourteen equities research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company. According to MarketBeat, Oracle has an average rating of “Moderate Buy” and an average target price of $145.83.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.